Gritstone bio, Inc.
GRTS · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $1,331 | $9,269 | $46,717 | $4,037 |
| % Growth | -85.6% | -80.2% | 1,057.2% | – |
| Cost of Goods Sold | $7,591 | $15,691 | $14,399 | $88,643 |
| Gross Profit | -$6,260 | -$6,422 | $32,318 | -$84,606 |
| % Margin | -470.3% | -69.3% | 69.2% | -2,095.8% |
| R&D Expenses | $127,182 | $111,403 | $97,490 | $88,643 |
| G&A Expenses | $28,783 | $28,970 | $25,933 | $21,411 |
| SG&A Expenses | $21,192 | $28,970 | $25,933 | $21,411 |
| Sales & Mktg Exp. | -$7,591 | $0 | $0 | $0 |
| Other Operating Expenses | -$32 | -$10,676 | -$1,497 | $0 |
| Operating Expenses | $148,374 | $129,697 | $121,926 | $110,054 |
| Operating Income | -$154,634 | -$120,428 | -$75,209 | -$106,017 |
| % Margin | -11,617.9% | -1,299.3% | -161% | -2,626.1% |
| Other Income/Exp. Net | $1,131 | $741 | $127 | $703 |
| Pre-Tax Income | -$138,490 | -$119,687 | -$75,082 | -$105,314 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$138,490 | -$113,127 | -$74,955 | -$104,611 |
| % Margin | -10,405% | -1,220.5% | -160.4% | -2,591.3% |
| EPS | -1.2 | -1.24 | -0.95 | -2.77 |
| % Growth | 3.2% | -30.5% | 65.7% | – |
| EPS Diluted | -1.2 | -1.24 | -0.95 | -2.77 |
| Weighted Avg Shares Out | 115,528 | 90,918 | 78,885 | 37,792 |
| Weighted Avg Shares Out Dil | 115,528 | 90,918 | 78,885 | 37,792 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5,199 | $1,976 | $164 | $715 |
| Interest Expense | $4,036 | $1,235 | $37 | $12 |
| Depreciation & Amortization | $7,591 | $15,691 | $14,399 | $6,644 |
| EBITDA | -$126,863 | -$111,892 | -$68,698 | -$98,670 |
| % Margin | -9,531.4% | -1,207.2% | -147.1% | -2,444.1% |